When complex health care regulations threaten a company’s future, reputation, or strategic deal, David Matyas negotiates favorable solutions for clients. He defends hospital systems, home care providers, physician practices, and other providers in government investigations, audits, and related claims of fraud, false claims, anti-kickback statute violations, and noncompliant behavior. In addition, David uses his regulatory depth to guide emerging health care companies and their private equity investors.

In an industry filled with uncertainty and change, David reduces legal risks for clients, which range from startups to industry leaders. He distills decades of regulatory law into common sense compliance programs and practical, strategic advice. Persuasive and diplomatic, David is most effective in contentious and sensitive matters, including negotiations with government authorities. His committed advocacy has helped eliminate or reduce clients’ exposure to program exclusion, criminal liability, corporate integrity agreements, and other penalties.

David is equally skilled before corporate boards, executive teams, entrepreneurs, and founders. Clients are reassured by the options he offers for growth, governance, and risk reduction at every stage of the business cycle.

Amid health care’s busy M&A activity, David’s deal regulatory due diligence is keeping private equity clients competitive. He identifies potential risks and pitfalls in target companies and offers remedies to prevent good deals from being derailed. David places clients ahead of quick-moving developments through his career-long leadership of the American Health Lawyers Association.

David is a frequent speaker and author on the subjects of health care fraud, corporate compliance programs, the Stark Law, mergers and acquisitions in the health care industry, and other health-related topics. He is also Managing Shareholder of Epstein Becker Green’s Washington, DC, office.


  • Negotiated a settlement to break an impasse in a government investigation of a multistate oncology services network. Working upon a request from the board of directors, David structured a unique agreement that created a windfall settlement for the government if the company was able to successfully sell itself upon finalizing a settlement. The company survived and went onto to pursue a successful growth strategy.
  • Represents a community health network in an ongoing, complex investigation, and related litigation, into the system’s acquisition of physician practices and possible violations of the Stark Law and the federal False Claims Act.
  • Has advised a home health and hospice company since its inception, steering its growth to a national platform and creating a staged approach to regulatory compliance programs that align with its continued expansion.
  • Led health care regulatory due diligence counsel covering several transactions by a private equity firm. David created the collaborative framework to refocus the deal’s many advisors into a cohesive team to close the deals on accelerated timelines.
  • University of Texas School of Law (J.D., 1992)
  • University of Pennsylvania (B.A., 1990)
Bar Admissions
  • District of Columbia
  • New Jersey
  • New York
  • American Bar Association
  • American Health Lawyers Association
Board of Directors
  • Community Health Accreditation Program (CHAP)
  • American Health Lawyers Association, Fellow
  • The Best Lawyers in America, Health Care Law (2011 to 2021)
  • BTI Client Service All-Star Team, Client Service MVP (2012 to 2013)
  • Chambers USA: The World's Leading Lawyers for Business, District of Columbia—Healthcare (2007 to 2021)
  • Leaders League, Best Law Firms for Healthcare (2020)
  • The Legal 500 United States (2014, 2016, 2018 to 2021); Legal Hall of Fame (2017, 2020, 2021); Leading Lawyer, Healthcare: Advice to Service Providers category (2015 to 2021)
  • Washington DC Super Lawyers, Health Care (2007 to 2021)
  • Who's Who Legal: Healthcare (2020)